Sagimet Biosciences Inc.(NASDAQ:SGMT) 
Sagimet Biosciences Inc., a clinical-stage biopharmaceutical company, develops therapeutics called fatty acid synthase (FASN) inhibitors to treat non-alcoholic steatohepatitis, acne, and various cancers. The company's lead drug candidate is Denifanstat, a fatty acid synthase inhibitor for the treatm...
Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 2.25
H 2.29
L 2.03
C 2.08
V 919,999
10EMA 2.08
20EMA 2.08
60EMA 2.08
120EMA 2.08
250EMA 2.08